Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
| Index | Market Cap | Enterprise Value | Income | Sales | Book/sh | Cash/sh | Dividend Est. | Dividend TTM | Dividend Ex-Date | Dividend Gr. 3/5Y | Payout | Employees | IPO |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RUT | 936.42M | 829.07M | -66.00M | 101.96M | 3.36 | 3.37 | - | - | - | - - | - | 327 | Oct 11, 2024 |